{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:47:27Z","timestamp":1777312047652,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UID \/04046\/2025"],"award-info":[{"award-number":["UID \/04046\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153757","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:16:03Z","timestamp":1776107763000},"page":"153757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dissecting the impact of SHC-1 inhibitors in enhancing the plasma membrane abundance of the CFTR channel across epithelial cell models"],"prefix":"10.1016","volume":"817","author":[{"given":"Patr\u00edcia","family":"Barros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana F.L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Tomilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Cortopassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-9696","authenticated-orcid":false,"given":"Paulo","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153757_bib1","series-title":"Advances in oto-rhino-laryngology","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000445134","article-title":"Acquired cystic fibrosis transmembrane conductance regulator deficiency","author":"Cho","year":"2016"},{"issue":"Suppl 2","key":"10.1016\/j.bbrc.2026.153757_bib2","first-page":"S150","article-title":"Cystic Fibrosis transmembrane conductance regulator. Implications in cystic Fibrosis and chronic obstructive pulmonary disease","volume":"13","author":"Cantin","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.bbrc.2026.153757_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153757_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","article-title":"Cystic Fibrosis transmembrane conductance Regulator function is suppressed in cigarette smokers","volume":"173","author":"Cantin","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2026.153757_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.13-0274","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD","volume":"144","author":"Dransfield","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.bbrc.2026.153757_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.11-192377","article-title":"Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration","volume":"26","author":"Clunes","year":"2012","journal-title":"FASEB j"},{"key":"10.1016\/j.bbrc.2026.153757_bib7","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1074\/jbc.M113.545137","article-title":"Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction","volume":"289","author":"Rasmussen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153757_bib8","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1111\/febs.12392","article-title":"Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi","volume":"280","author":"Farinha","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.153757_bib9","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1128\/MCB.05152-11","article-title":"Antagonistic regulation of cystic fibrosis transmembrane conductance regulator cell surface expression by protein kinases WNK4 and spleen tyrosine kinase","volume":"31","author":"Mendes","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153757_bib10","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1007\/s00018-020-03448-4","article-title":"A SYK\/SHC1 pathway regulates the amount of CFTR in the plasma membrane","volume":"77","author":"Loureiro","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153757_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/biom13060949","article-title":"YES1 kinase mediates the membrane removal of rescued F508del-CFTR in airway cells by promoting MAPK pathway activation via SHC1","volume":"13","author":"Barros","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.153757_bib12","doi-asserted-by":"crossref","DOI":"10.5334\/1750-2187-12-2","article-title":"Insights into the Shc family of adaptor proteins","volume":"12","author":"Ahmed","year":"2017","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.bbrc.2026.153757_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-019-1155-7","article-title":"The p52 isoform of SHC1 is a key driver of breast cancer initiation","volume":"21","author":"Wright","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153757_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.phrs.2018.09.024","article-title":"Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition","volume":"137","author":"Tomilov","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153757_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22876","article-title":"Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice","volume":"35","author":"Jiang","year":"2021","journal-title":"J Biochem & Molecular Tox"},{"key":"10.1016\/j.bbrc.2026.153757_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2008.12.011","article-title":"Angiotensin II and the development of insulin resistance: implications for diabetes","volume":"302","author":"Olivares-Reyes","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.153757_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31514-2","article-title":"Prolonged co-treatment with HGF sustains epithelial integrity and improves pharmacological rescue of Phe508del-CFTR","volume":"8","author":"Matos","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153757_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa1580","article-title":"A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint","volume":"8","author":"Loureiro","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2026.153757_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fphar.2019.00619","article-title":"Network biology identifies novel regulators of CFTR trafficking and membrane stability","volume":"10","author":"Loureiro","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153757_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","article-title":"Green fluorescent protein-based halide indicators with improved chloride and iodide affinities","volume":"499","author":"Galietta","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2026.153757_bib21","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M115.660498","article-title":"Signaling through the phosphatidylinositol 3-Kinase (PI3K)\/Mammalian target of Rapamycin (mTOR) axis is responsible for aerobic glycolysis mediated by glucose transporter in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma","volume":"290","author":"Makinoshima","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153757_bib22","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.2147\/OTT.S176818","article-title":"Inhibition of GLUT-1 expression and the PI3K\/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro","volume":"11","author":"Jiang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2026.153757_bib23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.bbrc.2026.153757_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110823","article-title":"Novel idebenone analogs block Shc's access to insulin receptor to improve insulin sensitivity","volume":"132","author":"Hui","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153757_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1165\/rcmb.2004-0012OC","article-title":"Activation of airway cl- secretion in human subjects by adenosine","volume":"31","author":"Hentchel-Franks","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153757_bib26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/ijms24021246","article-title":"Phenotypic alteration of an established human airway cell line by media selection","volume":"24","author":"Livnat","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153757_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcf.2004.05.035","article-title":"Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis","volume":"3","author":"Mall","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bbrc.2026.153757_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/ijms23031437","article-title":"Assays of CFTR function in vitro, Ex vivo and in vivo","volume":"23","author":"Ramalho","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.bbrc.2026.153757_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbrc.2026.153757_bib30","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s00018-016-2258-2","article-title":"The third dimension: new developments in cell culture models for colorectal research","volume":"73","author":"Pereira","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153757_bib31","article-title":"Evaluation of Caco-2 and human intestinal epithelial cells as in vitro models of colonic and small intestinal integrity","volume":"31","author":"Lopez-Escalera","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrc.2026.153757_bib32","article-title":"CFTR-mediated anion secretion in parathyroid hormone-treated Caco-2 cells is associated with PKA and PI3K phosphorylation but not intracellular pH changes or Na+\/K+-ATPase abundance","volume":"27","author":"Chaimana","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrc.2026.153757_bib33","doi-asserted-by":"crossref","DOI":"10.3791\/63528","article-title":"A fluorescence-based assay of membrane potential for high-throughput functional Study of two endogenous ion channels in two epithelial cell lines","author":"Xia","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbrc.2026.153757_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3892\/etm.2023.11942","article-title":"Alisertib exerts KRAS allele-specific anticancer effects on colorectal cancer cell lines","volume":"25","author":"Ren","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2026.153757_bib35","doi-asserted-by":"crossref","first-page":"13396","DOI":"10.1074\/jbc.RA119.008738","article-title":"Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant","volume":"294","author":"Matos","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153757_bib36","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1523\/JNEUROSCI.1632-17.2020","article-title":"Idebenone has distinct effects on mitochondrial respiration in cortical astrocytes compared to cortical neurons due to differential NQO1 activity","volume":"40","author":"Jaber","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153757_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2014.06.070","article-title":"Development of quinone analogues as dynamin GTPase inhibitors","volume":"85","author":"MacGregor","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153757_bib38","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3390\/cells12182312","article-title":"The chemical inhibitors of endocytosis: from mechanisms to potential clinical applications","volume":"12","author":"Szewczyk-Roszczenko","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153757_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.153757_bib40","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.3390\/cancers15174244","article-title":"Cystic Fibrosis and cancer: unraveling the complex role of CFTR gene in cancer susceptibility","volume":"15","author":"Parisi","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:10:46Z","timestamp":1777309846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26005218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0006291X26005218"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153757","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissecting the impact of SHC-1 inhibitors in enhancing the plasma membrane abundance of the CFTR channel across epithelial cell models","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153757"}}